Differential Induction of Inflammatory Cytokines and Reactive Oxygen Species in Murine Peritoneal Macrophages and Resident Fresh Bone Marrow Cells by Acute Staphylococcus aureus Infection: Contribution of Toll-Like Receptor 2 (TLR2)

Inflammation

Volumn 38, Issue 1, 2015, Pages 224-244

  Nandi, Ajeya ^a   Dey, Somrita ^a   Biswas, Julie ^a   Jaiswal, Pooja ^a   Naaz, Shamreen ^a   Yasmin, Tamima ^a   Bishayi, Biswadev ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

antioxidant enzymes; bone marrow cells; intracellular survival; murine peritoneal macrophages; Staphylococcus aureus; Swiss albino mice; Toll like receptor 2

Indexed keywords

CATALASE; GAMMA INTERFERON; HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; TLR2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL INTERACTION; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME ASSAY; IMMUNOMODULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; STAPHYLOCOCCUS INFECTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; CYTOKINES; INFLAMMATION MEDIATORS; MACROPHAGES, PERITONEAL; MICE; REACTIVE OXYGEN SPECIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 2;

EID: 84925543244     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-0026-8     Document Type: Article

References (93)

1. Lowy, F.D. 1998. Staphylococcus aureus infections. New England Journal of Medicine 339: 520–532.
2. Garzoni, C., and W.L. Kelley. 2009. Staphylococcus aureus: new evidence for intracellular persistence. Trends in Microbiology 17: 59–65.
3. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885–891.
4. Bronner, S., H. Monteil, and G. Prévost. 2004. Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. FEMS Microbiology Reviews 28: 183–200.
5. Wang, J.E., P.F. Jørgensen, M. Almlöf, C. Thiemermann, S.J. Foster, A.O. Aasen, and R. Solberg. 2000. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infection and Immunity 68: 3965–3970.
6. Müller-Anstett, M.A., P. Müller, T. Albrecht, M. Nega, J. Wagener, Q. Gao, S. Kaesler, M. Schaller, T. Biedermann, and F. Götz. 2010. Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes. PloS One 5: e13153.
7. Mattsson, E., R. Heying, J.S. van de Gevel, T. Hartung, and H. Beekhuizen. 2008. Staphylococcal peptidoglycan initiates an inflammatory response and procoagulant activity in human vascular endothelial cells: a comparison with highly purified lipoteichoic acid and TSST-1. FEMS Immunology and Medical Microbiology 52: 110–117.
8. Gillrie, M.R., L. Zbytnuik, E. McAvoy, R. Kapadia, K. Lee, C.C.M. Waterhouse, S.P. Davis, D.A. Muruve, P. Kubes, and M. Ho. 2010. Divergent roles of Toll-like receptor 2 in response to lipoteichoic acid and Staphylococcus aureus in vivo. European Journal of Immunology 40: 1639–1650.
9. Fournier, B., and D.J. Philpott. 2005. Recognition of Staphylococcus aureus by the innate immune system. Clinical Microbiology Reviews 18: 521–540.
10. Kubica, M., K. Guzik, J. Koziel, M. Zarebski, W. Richter, B. Gajkowska, A. Golda, A.M. Gudowska, K. Brix, L. Shaw, T. Foster, and J. Potempa. 2008. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PloS One 3: e1409.
11. Von Köckritz-Blickwede, M., M. Rohde, S. Oehmcke, L.S. Miller, A.L. Cheung, H. Herwald, S. Foster, and E. Medina. 2008. Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. American Journal of Pathology 173: 1657–1668.
12. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783–801.
13. Hoebe, K., P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zähringer, and B. Beutler. 2005. CD36 is a sensor of diacylglycerides. Nature 433: 523–527.
14. Silva, M.T. 2011. Macrophage phagocytosis of neutrophils at inflammatory/infectious foci: a cooperative mechanism in the control of infection and infectious inflammation. Journal of Leukocyte Biology 89: 675–683.
15. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805–820.
16. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, T. Ogawa, H. Takada, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11: 443–451.
17. Knuefermann, P., Y. Sakata, J.S. Baker, C.H. Huang, K. Sekiguchi, H.S. Hardarson, O. Takeuchi, S. Akira, and J.G. Vallejo. 2004. Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart. Circulation 110: 3693–3698.
18. Spiller, S., G. Elson, R. Ferstl, S. Dreher, T. Mueller, M. Freudenberg, B. Daubeuf, H. Wagner, and C.J. Kirschning. 2008. TLR-4 induced IFN-γ production increases TLR-2 sensitivity and drives Gram negative sepsis in mice. Journal of Experimental Medicine 205: 1747–1754.
19. Netea, M.G., J.W.M. Van der Meer, and B.J. Kullberg. 2004. Toll-like receptors as an escape mechanism from the host defense. Trends in Microbiology 12: 484–488.
20. Arko-Mensah, J., E. Julian, M. Singh, and C. Fernández. 2007. TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-γ induced killing of Mycobacteria by murine macrophages. Scandinavian Journal of Immunology 65: 148–157.
21. Watanabe, I., M. Ichiki, A. Shiratsuchi, and Y. Nakanishi. 2007. TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity. Journal of Immunology 178: 4917–4925.
22. Singh, A., D. Rost, N. Tvardovskaia, A. Roggenkamp, A. Wiedemann, C.J. Kirschning, M. Aepfelbacher, and J. Heesemann. 2002. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10 mediated immunosuppression. Journal of Experimental Medicine 196: 1017–1024.
23. Strunk, T., P. Richmond, A. Prosser, K. Simmer, O. Levy, D. Burgner, and A. Currie. 2011. Method of bacterial killing differentially affects the human innate immune response to Staphylococcus epidermidis. Innate Immunity 17: 508–516.
24. Dong, C., H. Sexton, A. Gertrudes, T. Akama, S. Martin, C. Virtucio, C.W. Chen, X. Fan, A. Wu, W. Bu, L. Liu, L. Feng, K. Jarnagin, and Y.R. Freund. 2013. Inhibition of Toll-like receptor-mediated inflammation in vitro and in vivo by a novel benzoxaborole. Journal of Pharmacology and Experimental Therapeutics 344: 436–446.
25. Kondo, T., T. Kawai, and S. Akira. 2012. Dissecting negative regulation of Toll-like receptor signaling. Trends in Microbiology 33: 450–460.
26. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. Journal of Immunology 165: 5392–5396.
27. Shin, J.E., Y.S. Kim, J.E. Oh, B.M. Min, and Y. Choi. 2010. Treponema denticola suppresses expression of human beta defensin-3 in gingival epithelial cells through inhibition of the toll-like receptor 2 axis. Infection and Immunity 78: 672–679.
28. 2 produced by the murine peritoneal macrophages. Microbial Pathogenesis 47: 57–67.
29. Paul-Clark, M.J., S.K. McMaster, and R. Sorrentino. 2009. Toll-like receptor 2 is essential for sensing of oxidants during inflammation. American Journal of Respiratory and Critical Care Medicine 179: 299–306.
30. Sorci, G., and B. Faivre. 2009. Inflammation and oxidative stress in vertebrate host-parasite system. Philosophical Transactions of the Royal Society B 364: 71–83.
31. West, A.P., I.E. Brodsky, C. Rahner, D.K. Woo, H. Erdjument-Bromage, P. Tempst, M.C. Walsh, Y. Choi, S. Gerald, G.S. Shadel, and S. Ghosh. 2011. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 272: 476–482.
32. Martínez-Pulgarín, S., G. Dominguez-Bernal, J.A. Orden, and R. de la Fuente. 2009. Simultaneous lack of catalase and beta-toxin in Staphylococcus aureus leads to increased intracellular survival in macrophages and epithelial cells and to attenuated virulence in murine and ovine models. Microbiology 155: 1505–1515.
33. Mal, P., S. Dutta, D. Bandyopadhyay, K. Dutta, A. Basu, and B. Bishayi. 2012. Gentamicin in combination with ascorbic acid regulates the severity of Staphylococcus aureus infection-induced septic arthritis in mice. Scandinavian Journal of Immunology 76: 528–540.
34. Mathias, S., J.J. Naja, F. Ferracin, and R. Landmann. 2011. T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2–MyD88-dependent T cell activation. Journal of Immunology 186: 443–452.
35. Marim, F.M., T.N. Silveira, D.S. Lima Jr., and D.S. Zamboni. 2010. A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells. PloS One 5: e15263.
36. Das, D., and B. Bishayi. 2010. Contribution of catalase and superoxide dismutase to the intracellular survival of clinical isolates of Staphylococcus aureus in murine macrophages. Indian Journal of Microbiology 50: 375–384.
37. + T cell activation via Toll-like receptors 1 and 2. Infection and Immunity 79: 663–673.
38. Swisher, J.F.A., N. Burton, S.M. Bacot, S.N. Vogel, and G.M. Feldman. 2010. Annexin A2 tetramer activates human and murine macrophages through TLR4. Blood 115: 549–558.
39. Gebbia, J.A., J.L. Coleman, and J.L. Benach. 2004. Selective induction of matrix metalloproteinases by Borrelia burgdorferi via Toll-like receptors 2 in monocyte. Journal of Infectious Diseases 189: 113–119.
40. Sen, R., D. Das, and B. Bishayi. 2010. Staphylococcal catalase regulates its virulence and induces arthritis in catalase deficient mice. Indian Journal of Physiology and Pharmacology 53: 307–317.
41. Leigh, P.C.J., R. van Furth, and T.L. van Zwet. 1986. In vitro determination of phagocytosis and intracellular killing by polymorphonuclear and mononuclear phagocytes. In Handbook of experimental Immunology, ed. D.M. Weir, 46.1–46.26. Oxford: Blackwell Scientific.
42. Absolom, D.R. 1986. Basic methods for the study of phagocytosis. Methods Enzymology 132: 95–180.
43. Bae, Yun Soo, Jee Hyun Lee, Soo Ho. Choi, Sunah Kim, Felicidad Almazan, Joseph L. Witztum, and Yury I. Miller. 2009. Macrophages generate reactive oxygen species in response to minimally oxidized low density lipoprotein: Toll like receptor 4 and spleen tyrosine kinase dependent activation of NADPH oxidase-2. Circulation Research 104: 210–218.
44. Nandi, D., M.K. Mishra, A. Basu, and B. Bishayi. 2010. Protective effects of interleukin-6 in lipopolysaccharide (LPS)-induced experimental endotoxemia is linked to alteration in hepatic anti-oxidant enzymes and endogenous cytokines. Immunobiology 215: 443–451.
45. Mal, P., D. Ghosh, D. Bandyopadhyay, K. Dutta, and B. Bishayi. 2012. Ampicillin alone and in combination with riboflavin modulates Staphylococcus aureus infection induced septic arthritis in mice. Indian Journal of Experimental Biology 50: 677–689.
46. Bishayi, B., D. Bandyopadhyay, A. Majhi, and R. Adhikary. 2014. Possible role of Toll like receptor-2 (TLR-2) in the intracellular survival of Staphylococcus aureus in murine peritoneal macrophages: involvement of cytokines and anti-oxidant enzymes. Scandinavian Journal of Immunology 80: 127–143.
47. Miller, R.A., and B.E. Britigan. 1997. Role of oxidants in microbial pathophysiology. Clinical Microbiology Reviews 10: 1–18.
48. Philippart, F., C. Fitting, and J.M. Cavaillon. 2012. Lung microenvironment contributes to the resistance of alveolar macrophages to develop tolerance to endotoxin. Critical Care Medicine 40: 2987–2996.
49. Gautier, E.L., T. Shay, J. Miller, M. Greter, C. Jakubzick, S. Ivanov, J. Helft, A. Chow, K.G. Elpek, S. Gordonov, A.R. Mazloom, A. Ma’ayan, W.J. Chua, T.H. Hansen, S.J. Turley, M. Merad, and G.J. Randolph. 2012. Gene expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nature Immunology 13: 1118–1128.
50. Michelsen, K.S., A. Aicher, M. Mohaupt, T. Hartung, S. Dimmeler, C.J. Kirschning, and R.R. Schumann. 2001. The role of Toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS): peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. Journal of Biological Chemistry 276: 25680–25686.
51. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C.J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll like receptor 2. Journal of Biological Chemistry 274: 17406–17409.
52. Dziarski, R., and D. Gupta. 2005. Staphylococcus aureus peptidoglycan is a Toll-like receptor 2 activator: a reevaluation. Infection and Immunity 73: 5212–5216.
53. Mae, M., M. Iyori, M. Yasuda, H.M. Shamsul, H. Kataoka, K. Kiura, A. Hasebe, Y. Totsuka, and K. Shibata. 2007. The diacylated lipopeptide FSL-1 enhances phagocytosis of bacteria by macrophages through a Toll-like receptor 2-mediated signaling pathway. FEMS Immunology and Medical Microbiology 49: 398–409.
54. Jann, N.J., M. Schmaler, F. Ferracin, and R. Landmann. 2011. TLR2 enhances NADPH oxidase activity and killing of Staphylococcus aureus by PMN. Immunology Letters 135: 17–23.
55. Stuart, L.M., J. Deng, J.M. Silver, K. Takahashi, A.A. Tseng, E.J. Hennessy, R.A.B. Ezekowitz, and K.J. Moore. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. Journal of Cell Biology 170: 477–485.
56. Yimin, M. Kohanawa, Z. Songji, M. Ozaki, S. Haga, G. Nan, Y. Kuge, and N. Tamaki. 2013. Contribution of Toll-like receptor 2 to the innate response against Staphylococcus aureus infection in mice. PloS One 9: e74287.
57. Rigby, K.M., and F.R. DeLeo. 2012. Neutrophils in innate host defense against Staphylococcus aureus infections. Seminars in Immunopathology 34: 237–259.
58. Heumann, D., C. Barras, A. Severin, M.P. Glauser, and A. Tomasz. 1994. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infection and Immunity 62: 2715–2721.
59. Timmerman, C.P., E. Mattsson, L. Martinez-Martinez, L. De Graaf, J.A. Van Strijp, H.A. Verbrugh, J. Verhoef, and A. Fleer. 1993. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infection and Immunity 61: 4167–4172.
60. Wakabayashi, G., J.A. Gelfand, W.K. Jung, R.J. Connolly, J.F. Burke, and C.A. Dinarello. 1991. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. Journal of Clinical Investigation 87: 1925–1935.
61. Jiang, W., B. Li, X. Zheng, X. Liu, Y. Cen, J. Li, X. Pan, H. Cao, J. Zheng, and H. Zhou. 2011. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin. International Immunopharmacology 11: 1065–1073.
62. Frodermann, V., T.A. Chau, S. Sayedyahossein, J.M. Toth, D.E. Heinrichs, and J. Madrenas. 2011. A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus. Journal of Infectious Diseases 204: 253–262.
63. Manicassamy, S., and B. Pulendran. 2009. Modulation of adaptive immunity with Toll-like receptors. Seminars in Immunology 21: 185–193.
64. Deshmukh, H.S., J.B. Hamburger, S.H. Ahn, D.G. McCafferty, S.R. Yang, G. Vance, and Fowler Jr. 2009. Critical role of NOD2 in regulating the immune response to Staphylococcus aureus. Infection and Immunity 77: 1376–1382.
65. Schindler, H., M.B. Lutz, M. Röllinghoff, and C. Bogdan. 2001. The production of IFN-γ by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. Journal of Immunology 166: 3075–3082.
66. Presky, D.H., H. Yang, L.J. Minetti, A.O. Chua, N. Nabavi, C.Y. Wu, M.K. Gately, and U. Gubler. 1996. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proceedings of the National Academy of Sciences of the United States of America 93: 14002–14007.
67. Torres, D., M. Barrier, F. Bihl, V.J.F. Quesniaux, I. Maillet, S. Akira, B. Ryffel, and F. Erard. 2004. Toll-like receptor 2 is required for optimal control of Listeria monocytogenes infection. Infection and Immunity 72: 2131–2139.
68. Conroy, H., N.A. Marshall, and K.H. Mills. 2008. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumors. Oncogene 27: 168–180.
69. Henderson, B., and S.P. Nair. 2003. Hard labour: bacterial infection of the skeleton. Trends in Microbiology 11: 570–577.
70. Ellington, J.K., S.S. Reilly, W.K. Ramp, M.S. Smeltzer, J.F. Kellam, and M.C. Hudson. 1999. Mechanisms of Staphylococcus aureus invasion of cultured osteoblasts. Microbial Pathogenesis 26: 317–323.
71. Hudson, M.C., W.K. Ramp, N.C. Nicholson, A.S. Williams, and M.T. Nousiainen. 1995. Internalization of Staphylococcus aureus by cultured osteoblasts. Microbial Pathogenesis 19: 409–419.
72. Jevon, M., C. Guo, B. Ma, N. Mordan, S.P. Nair, M. Harris, B. Henderson, G. Bentley, and S. Meghji. 1999. Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblasts. Infection and Immunity 67: 2677–2681.
73. Khalil, H., R.J. Williams, G. Stenbeck, B. Henderson, S. Meghji, and S.P. Nair. 2007. Invasion of bone cells by Staphylococcus epidermidis. Microbes and Infection 9: 460–465.
74. Reilly, S.S., M.C. Hudson, J.F. Kellam, and W.K. Ramp. 2000. In vivo internalization of Staphylococcus aureus by embryonic chick osteoblasts. Bone 26: 63–70.
75. Kwan, T.S., M. Padrines, S. Theoleyre, D. Heymann, and Y. Fortun. 2004. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Reviews 15: 49–60.
76. Mundy, G.R. 1991. Inflammatory mediators and the destruction of bone. Journal of Periodontal Research 26: 213–217.
77. Pfeilschifter, J., C. Chenu, A. Bird, G.R. Mundy, and G.D. Roodman. 1989. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. Journal of Bone and Mineral Research 4: 113–118.
78. Tokukoda, Y., S. Takata, H. Kaji, R. Kitazawa, T. Sugimoto, and K. Chihara. 2001. Interleukin-1beta stimulates transendothelial mobilization of human peripheral blood mononuclear cells with a potential to differentiate into osteoclasts in the presence of osteoblasts. Journal of Endocrinology 48: 443–452.
79. Ishimi, Y., C. Miyaura, C.H. Jin, T. Akatsu, E. Abe, Y. Nakamura, A. Yamaguchi, S. Yoshiki, T. Matsuda, and T. Hirano. 1990. IL-6 is produced by osteoblasts and induces bone resorption. Journal of Immunology 145: 3297–3303.
80. Kotake, S., K. Sato, K.J. Kim, N. Takahashi, N. Udagawa, I. Nakamura, A. Yamaguchi, T. Kishimoto, T. Suda, and S. Kashiwazaki. 1996. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. Journal of Bone and Mineral Research 11: 88–95.
81. Meghji, S., S.J. Crean, P.A. Hill, M. Sheikh, S.P. Nair, K. Heron, B. Henderson, E.B. Mawer, and M. Harris. 1998. Surface-associated protein from Staphylococcus aureus stimulates osteoclastogenesis: possible role in S. aureus-induced bone pathology. British Journal of Rheumatology 37: 1095–1101.
82. Nair, S., Y. Song, S. Meghji, K. Reddi, M. Harris, A. Ross, S. Poole, M. Wilson, and B. Henderson. 1995. Surface-associated proteins from Staphylococcus aureus demonstrate potent bone resorbing activity. Journal of Bone and Mineral Research 10: 726–734.
83. Yokoyama, R., S. Itoh, G. Kamoshida, T. Takii, S. Fujii, T. Tsuji, and K. Onozakia. 2012. Staphylococcal superantigen-like protein 3 binds to the Toll-like receptor 2 extracellular domain and inhibits cytokine production induced by Staphylococcus aureus, cell wall component, or lipopeptides in murine macrophages. Infection and Immunity 80: 2816–2825.
84. Wright, J.A., and S.P. Nair. 2010. Interaction of staphylococci with bone. International Journal of Medical Microbiology 300: 193–204.
85. Bosse, M.J., H.E. Gruber, and W.K. Ramp. 2005. Internalization of bacteria by osteoblasts in a patient with recurrent, long-term osteomyelitis: a case report. Journal of Bone and Joint Surgery 87: 1343–1347.
86. Hamza, T., M. Dietz, D. Pham, N. Clovis, S. Danley, and B. Li. 2013. Intracellular Staphylococcus aureus alone causes infection in vivo. European Cells and Materials 25: 341–350.
87. Facecchia, K., L.A. Fochesato, S.D. Ray, S.J. Stohs, and S. Pandey. 2011. Oxidative toxicity in neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strategies. Journal of Toxicology:Article ID 683728. doi:10.1155/2011/683728
88. Hampton, M.B., A.J. Kettle, and C.C. Winterbourn. 1998. Inside the neutrophil phagosome: oxidants, myeloperoxidase and bacterial killing. Blood 92: 3007–3017.
89. Stor, Z.G., L.A. Tartaglia, S.B. Farr, and B.N. Ames. 1990. Bacterial defense against oxidative stress. Trends in Genetics 6: 363–368.
90. Bogdan, C., M. Rollinghoff, and A. Diefenach. 2000. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Current Opinion Immunology 12: 64–76.
91. 2 via their high basal and inducible levels of catalase activity. Journal of Biological Chemistry 276: 24360–24364.
92. Tripp, C.S., S.F. Wolf, and E.R. Unanue. 1993. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proceedings of the National Academy of Sciences of the United States of America 90: 3725–3729.
93. Bishayi, B., D. Bandyopadhyay, A. Majhi, and R. Adhikary. 2014. Expression of CXCR1 (interleukin-8 receptor) in murine macrophages after Staphylococcus aureus infection and its possible implication on intracellular survival correlating with cytokines and bacterial anti-oxidant enzymes. Inflammation. doi:10.1007/s10753-014-9991-1.